BridgeMD
New treatment option for Healthy Volunteers
Official title Effects of Energy Drinks on Cardiovascular Endpoints
ClinicalTrials.gov ID: NCT07212803
What this study is testing
- What it's testing
- This is a clinical trial looking at the impact of energy drinks on heart related parameters. The study will enroll 3 participants who will be exposed to 8 different interventions.
- Phase 4: studies an already-approved treatment
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40. Healthy volunteers may be eligible.
You may be able to join if
- Healthy male or female adults 18-40 years of age
- Female participants of child-bearing potential must have a negative pregnancy test at the baseline visit
- Participants must be willing to refrain from caffeine and alcohol use 72 hours prior to sessions on study days
- Participants must be willing and able to: (1.) Consume up to 1 liter of fluid within a 30-minute period per visit (2.) Swallow a single large capsule...
- Participants must be willing to fast 10 hours prior to sessions on study days (only water is allowed during the fasting and active study period)
You likely can't join if
- Have a corrected QT (QTc) interval greater than 450 milliseconds (ms) for males or greater than 470 milliseconds (ms) for females, determined during...
- Presence of any known medical condition, confirmed through participant interview. Examples of these include but not limited to: Dyslipidemia, Thyroid...
- Presence of any known heart/cardiac diseases or conditions such as: Atrial Fibrillation, History of stroke or heart attack, Hypertension, Heart...
- Study physician recommendation for participant to not be enrolled.
- Are underweight (BMI\<18.5 kg/m2, CDC 2024), have poor eating habits resulting in poor weight control, or have any factors that will put the...
- Have any contraindications to the use of moxifloxacin, including a past medical history of myasthenia gravis, QT prolongation, or hypersensitivities...
See the full eligibility criteria
- Healthy male or female adults 18-40 years of age
- Female participants of child-bearing potential must have a negative pregnancy test at the baseline visit
- Participants must be willing to refrain from caffeine and alcohol use 72 hours prior to sessions on study days
- Participants must be willing and able to: (1.) Consume up to 1 liter of fluid within a 30-minute period per visit (2.) Swallow a single large capsule per visit
- Participants must be willing to fast 10 hours prior to sessions on study days (only water is allowed during the fasting and active study period)
- Participants must have active health insurance throughout the duration of the study
- Have a corrected QT (QTc) interval greater than 450 milliseconds (ms) for males or greater than 470 milliseconds (ms) for females, determined during the baseline visit
- Presence of any known medical condition, confirmed through participant interview. Examples of these include but not limited to: Dyslipidemia, Thyroid disease, Diabetes, Recurrent headache, Any psychiatric condition or...
- Presence of any known heart/cardiac diseases or conditions such as: Atrial Fibrillation, History of stroke or heart attack, Hypertension, Heart Failure, Vascular Disease, Family history/Active Long QT Syndrome, Coronary...
- Study physician recommendation for participant to not be enrolled.
- Are underweight (BMI\<18.5 kg/m2, CDC 2024), have poor eating habits resulting in poor weight control, or have any factors that will put the participant at risk from fasting.
- Have any contraindications to the use of moxifloxacin, including a past medical history of myasthenia gravis, QT prolongation, or hypersensitivities and allergic reactions to moxifloxacin or any other fluoroquinolone...
- Pre-existing risk to tendinitis and tendon rupture, peripheral neuropathy, or central nervous system side effects
- Concurrent use of ANY medication taken daily including herbal products or supplements (daily basis is defined as greater than 2 days per week)
- Self-reported allergy to taurine
- Self-reported allergy to nuts (peanuts, pecans, cashews, etc.)
- Self-reported allergic reaction to the adhesive pads (electrodes, continuous glucose monitors, etc.)
- Fear of needle puncture
- Smokers using cigarettes, vaporized nicotine, or marijuana products currently or within the past month
- Current usage of any nicotine or tobacco products including but not limited to intranasal, sublingual, oral, or transdermal dosage forms
- Currently pregnant or breastfeeding
- Have a positive pregnancy test during the baseline visit
- Are currently enrolled in any other clinical study or have participated in another study within the last 30 days
- Non-English speaking/reading individuals will be excluded due to the unavailability of medically qualified translators throughout all study procedures
- If the candidate does not sign the informed consent document
The study team makes the final eligibility decision.
Where it's taking place
- Stockton, California, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockton, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.